Latest:
Dr. Bakouny on Understanding the Biology of Translocation RCC
Ziad Bakouny, MD, MSc, discusses understanding the biology of translocation renal cell carcinoma.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Zofia Piotrowska, MD, Massachusetts General Hospital Cancer Center
Latest:
Experts Discuss Management of Skin and Mouth TRAEs Associated With EGFR TKIs
Christine Lovly, MD, PhD, Jeanne G. Vaughn, NP, Kristina Lo, PharmD, BCOP, and Linda Ahn discuss how to approach treatment-related adverse effects of the skin and mouth associated with the use of EGFR TKIs.
Zofia Piotrowska, MD, MHS
Latest:
Balancing Safety and Efficacy With ADC-Based Therapies in Advanced EGFRm Non–Small Cell Lung Cancer
Panelists discuss how ADC-based therapies like dato-DXd offer superior efficacy compared with traditional chemotherapy options like docetaxel, while requiring careful monitoring for unique toxicities including ILD, stomatitis, and ocular effects.
David L. Saltman, MD, PhD
Latest:
Dr. Saltman on the Use of the DetermaIO Assay to Inform Immunotherapy Use in Advanced-Stage NSCLC
David L. Saltman, MD, PhD, discusses the use of the 27-gene Determa immuno-oncology assay to inform use of single-agent immunotherapy in patients with advanced-stage non–small cell lung cancer.